MXC MGC Pharmaceuticals

EQS-News: MGC Pharmaceuticals delivers its largest-ever order

EQS-News: MGC Pharmaceuticals Ltd
MGC Pharmaceuticals delivers its largest-ever order

08.12.2022 / 14:46 CET/CEST
The issuer is solely responsible for the content of this announcement.

Contact Details

Proactive

Proactive UK Ltd

3


News Source: News Direct

08.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com
Language: English
Company: MGC Pharmaceuticals Ltd
United States
ISIN: AU000000MXC6
EQS News ID: 1508695

 
End of News EQS News Service

1508695  08.12.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1508695&application_name=news&site_id=research_pool
EN
08/12/2022

Underlying

MXCMGC Pharmaceuticals

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MGC Pharmaceuticals

Daniel Appiah ... (+3)
  • Daniel Appiah
  • John Savin PhD
  • Robin Davison
MXC MGC Pharmaceuti...

Funding to progress CannEpil, with CimetrA data soon

MGC Pharmaceuticals is an emerging pharmaceutical company selling plant-derived, medicinal products in the UK, Ireland and Australia. Core marketed products are the food supplement, ArtemiC, promoted to help reduce COVID-19 symptoms, and medicinal cannabis products sold in Australia, UK and Ireland

MXC MGC PHARMACEUTICALS
04/21/23 April 21, 2023 1 EN
 PRESS RELEASE
Free
MXC MGC Pharmaceuti...

EQS-News: MGC Pharmaceuticals delivers its largest-ever order

EQS-News: MGC Pharmaceuticals Ltd MGC Pharmaceuticals delivers its largest-ever order 08.12.2022 / 14:46 CET/CEST The issuer is solely responsible for the content of this announcement. Contact DetailsProactiveProactive UK Ltd 3News Source: News Direct 08.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at -news.com Language:...

December 8, 2022 1 EN
Daniel Appiah ... (+3)
  • Daniel Appiah
  • John Savin PhD
  • Robin Davison
MXC MGC Pharmaceuti...

MGC Pharma funded to drive projects

MGC Pharmaceuticals Ltd sells plant-derived, medicinal products in the UK, Ireland and Australia. Core marketed products are a food supplement, ArtemiC, to help overcome COVID-19 infection and medicinal cannabis products sold in Australia, UK and Ireland. A dramatic new initiative is the new medica

MXC MGC PHARMACEUTICALS
08/16/22 August 16, 2022 1 EN
Robin Davison
  • Robin Davison
MXC MGC Pharmaceuti...

Cannabinoids combat brain cancer cells

MCG Pharmaceuticals has reported some new data from preclinical laboratory studies done by its research collaborator, Slovenia's National Institute of Biology. The data highlights the possible use of cannabinoids in the treatment of glioblastoma multiforme (GBM), the aggressive, and most common, br

MXC MGC PHARMACEUTICALS
06/20/22 June 20, 2022 1 EN
John Savin PhD
  • John Savin PhD
MXC MGC Pharmaceuti...

CannEpil trial due to start in June 2022

MCG sells medicinal cannabis products in the UK, Ireland, and Australia. Sales in the third quarter of the year to the end of March 2022 (Q3FY22) were A$550k, taking the fiscal year to date (YTD) total up to A$1.8mln. Sales of an anti-inflammatory, plant-based food supplement (ArtemiC) marketed for

MXC MGC PHARMACEUTICALS
06/07/22 June 7, 2022 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch